This trial is studying how menopause affects weight gain and risk for diseases like cardiovascular disease and diabetes.
- Abdominal Obesity
2 Primary · 5 Secondary · Reporting Duration: Baseline, week 12, week 24
Awards & Highlights
5 Treatment Groups
Premenopausal: GnRH antagonist + estradiol
1 of 5
Premenopausal: GnRH antagonist + placebo
1 of 5
Postmenopausal: GnRH antagonist + estradiol
1 of 5
Postmenopausal: GnRH antagonist + placebo
1 of 5
Postmenopausal: placebo + placebo
1 of 5
57 Total Participants · 5 Treatment Groups
Primary Treatment: Estrogen Product · Has Placebo Group · Phase 4
Who is running the clinical trial?
Age 40 - 65 · Female Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||50.0%|
Why did patients apply to this trial?
- "I have tired3 other drugs and nothing I am hoping that this trial will help me so I can help others"
How many prior treatments have patients received?
Frequently Asked Questions
Could you provide an overview of prior investigations surrounding Estrogen Product?
"Presently, there are 120 trials analyzing Estrogen Product with 25 of those currently in their final phase. The majority are situated in Duarte California but the medication is being tested at 3485 different sites around the world." - Anonymous Online Contributor
To what degree can Estrogen Product be deleterious to patients?
"Estrogen Product has been approved, which is reflected in its score of 3 for safety." - Anonymous Online Contributor
What is the total recruitment capacity for this clinical trial?
"That is correct. According to information hosted on clinicaltrials.gov, the trial was first launched in September 2019 and has since been actively recruiting patients for participation. A total of 57 participants are sought at a single medical centre." - Anonymous Online Contributor
To whom is the opportunity to participate in this clinical trial offered?
"This clinical trial necessitates that applicants be between 40 and 65 years old, suffer from obesity, and have visceral fat to qualify. The research is hoping to accrue a total of 57 participants." - Anonymous Online Contributor
What medical maladies is Estrogen Product commonly administered to alleviate?
"Estrogen Product is commonly employed to treat women with no menstrual period in the past 6 months, as well as hypoestrogenism, vasomotor symptoms related to menopause, and breast cancer." - Anonymous Online Contributor
Are any new participants being accepted into this experiment at present?
"Affirmative. According to clinicaltrials.gov, the research is actively seeking participants and was originally published on September 24th 2019 before being modified lastly on October 19th 2022. 57 individuals from a single study location are required for this medical trial." - Anonymous Online Contributor
What positive outcomes is this trial hoping to manifest?
"This medical trial, to be assessed over a Baseline and week 12 time period, intends to determine the alteration in Oral Cortisone Challenge (OCC) Area Under the Curve (AUC). Secondary goals include an evaluation of deviation in resting energy expenditure (REE), flow-mediated dilation (FMD), as well as visceral fat area (VFA). REE is an index of metabolism while at rest; conversely FMD measures vascular health. Finally VFA elucidates how much fat is stored within the abdominal region." - Anonymous Online Contributor
Does this clinical trial permit elderly individuals to participate?
"As laid out by the inclusion criteria for this trial, patients between 40 and 65 years old are eligible. Conversely, there are 33 studies targeting those under 18 while 362 trials offer assistance to people beyond retirement age." - Anonymous Online Contributor